Top Story

Fox Chase Cancer Center announces faculty appointments

September 25, 2016

Fox Chase Cancer Center announced several faculty appointments.

Allison Aggon , DO, has joined the department of surgical oncology with a focus on breast surgery.


Navigating the National Health System: A personal experience

HemOnc Today, September 25, 2016
Jai N. Patel, PharmD
An experience abroad had me contemplating the state of our health system in the United States and the implications of nationalized health care. It is evident that no…

Two NSCLC trials fail to meet primary endpoints

HemOnc Today, September 25, 2016
Two randomized phase 3 trials designed to evaluate treatments for patients with non–small cell lung cancer failed to meet their primary endpoints of PFS. The…
Cover Story

Frequent, effective communication may minimize ‘financial toxicity’ of cancer treatments

HemOnc Today, September 25, 2016
Targeted therapies, immunotherapies and more advanced surgical procedures have dramatically improved cancer outcomes. However, progress has come at a steep cost.

Treating the primary in metastatic prostate cancer

HemOnc Today, September 25, 2016
Derek Raghavan, MD, PhD
Rusthoven and colleagues recently reported a post-hoc analysis of 6,382 men with newly diagnosed metastatic prostate cancer treated with androgen deprivation therapy, of…
More News Headlines »

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Meeting News Coverage

VIDEO: Combination of anti-PD-1 inhibitors with new immune-modulators produces ‘exciting’ results in solid tumors

August 31, 2016
More »
At Issue: Breast Cancer Resource Center

At Issue: Breast Cancer Resource Center


The Patient with Multiple Ecchymoses

No commercial support for this activity.

Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin…
More »
Current Issues
View the Current Issue
HemOnc Today